Article Details

Analysts Anticipate Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) to Post -$0.11 EPS

Retrieved on: 2022-05-22 22:21:19

Tags for this article:

Click the tags to see associated articles and topics

Analysts Anticipate Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) to Post -$0.11 EPS. View article details on hiswai:

Excerpt

The biotechnology company reported ($0.07) earnings per share for the quarter, beating the consensus estimate of ($0.12) by $0.05.

Article found on: www.etfdailynews.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up